{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15330498", "DateCompleted": {"Year": "2004", "Month": "09", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0944-7113", "JournalIssue": {"Volume": "11", "Issue": "5", "PubDate": {"Year": "2004", "Month": "Jul"}}, "Title": "Phytomedicine : international journal of phytotherapy and phytopharmacology", "ISOAbbreviation": "Phytomedicine"}, "ArticleTitle": "Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents.", "Pagination": {"StartPage": "424", "EndPage": "430", "MedlinePgn": "424-30"}, "Abstract": {"AbstractText": ["Caffeic acid and quercetin, the well-known phenolic compounds widely present in the plant kingdom, were investigated for their possible protective effects against paracetamol and CCl4-induced hepatic damage. Paracetamol at the oral dose of 1 g/kg produced 100% mortality in mice while pretreatment of separate groups of animals with caffeic acid (6 mg/kg) and quercetin (10 mg/kg) reduced the death rate to 20% and 30%, respectively. Oral administration of sub-lethal dose of paracetamol (640 mg/kg) produced liver damage in rats as manifested by the significant (P<0.01) rise in serum levels of aminotransferases (aspartate transaminase (AST) and alanine transaminase (ALT)) compared to respective control values. The serum enzyme values were significantly (P<0.01) lowered on pretreatment of rats with either caffeic acid (6 mg/kg) or quercetin (10 mg/kg). Similarly, the hepatotoxic dose of CCl4 (1.5 ml/kg; orally) also raised significantly (P<0.05) the serum AST and ALT levels as compared to control values. The same dose of the caffeic acid and quercetin was able to prevent CCl4-induced rise in serum enzymes. Caffeic acid and quercetin also prevented the CCl4-induced prolongation in pentobarbital sleeping time confirming their hepatoprotectivity. These results indicate that caffeic acid and quercetin exhibited hepatoprotective activity possibly through multiple mechanisms."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan."}], "Identifier": [], "LastName": "Janbaz", "ForeName": "K H", "Initials": "KH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Saeed", "ForeName": "S A", "Initials": "SA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gilani", "ForeName": "A H", "Initials": "AH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Phytomedicine", "NlmUniqueID": "9438794", "ISSNLinking": "0944-7113"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Caffeic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "362O9ITL9D", "NameOfSubstance": "Acetaminophen"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}, {"RegistryNumber": "CL2T97X0V0", "NameOfSubstance": "Carbon Tetrachloride"}, {"RegistryNumber": "EC 2.6.1.1", "NameOfSubstance": "Aspartate Aminotransferases"}, {"RegistryNumber": "EC 2.6.1.2", "NameOfSubstance": "Alanine Transaminase"}, {"RegistryNumber": "U2S3A33KVM", "NameOfSubstance": "caffeic acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Acetaminophen"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["blood"], "DescriptorName": "Alanine Transaminase"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["blood"], "DescriptorName": "Aspartate Aminotransferases"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Caffeic Acids"}, {"QualifierName": [], "DescriptorName": "Carbon Tetrachloride"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Protective Agents"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "8", "Day": "28", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "9", "Day": "17", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "8", "Day": "28", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15330498", "10.1016/j.phymed.2003.05.002", "S0944-7113(04)00012-1"]}}], "PubmedBookArticle": []}